Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Innoviva, Inc.(INVA) | 7,277,000 | 7,277,000 | 0 | $140.52M | $126.26M | 39.11% | -$14.26M |
| Ironwood Pharmaceuticals, Inc.CL A(IRWD) | 16,390,000 | 16,390,000 | 0 | $67.53M | $72.61M | 22.49% | +$5.08M |
| Neurocrine Biosciences, Inc.(NBIX) | 410,483 | 309,116 | -101,367 | $47.30M | $42.19M | 13.07% | -$5.10M |
| Cytokinetics, Incorporated(CYTK) | 1,110,000 | 833,799 | -276,201 | $58.61M | $39.22M | 12.15% | -$19.39M |
| Gilead Sciences, Inc.(GILD) | 763,333 | 262,080 | -501,253 | $64.00M | $24.21M | 7.50% | -$39.79M |
| Amarin Corp PlcADR | 24,850,623 | 24,850,623 | 0 | $15.58M | $12.05M | 3.73% | -$3.53M |
| Lantheus Holdings, Inc.(LNTH) | 26,000 | 63,000 | +37,000 | $2.85M | $5.64M | 1.75% | +$2.78M |
| Vor Biopharma Inc.(VOR) | 618,000 | 618,000 | 0 | $432.6K | $686.0K | 0.21% | +$253.4K |
| Biogen Inc.(BIIB) | 26,950 | 0 | -26,950 | $5.22M | $0 | — | -$5.22M |
| Regulus Therapeutics Inc | 185,183 | 0 | -185,183 | $290.7K | $0 | — | -$290.7K |